Techlab, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Apr 2032
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Nov 21, 2026
- 1 fee due Mar 15, 2027The maintenance fee for CELL WALL PROTEIN CwpV (CD0514) AS A DIAGNOSTIC MARKER FOR CLOSTRIDIUM DIFFICILE RIBOTYPE 027 (US 9,133,527) comes due Mar 15, 2027. Unpaid by Sep 15, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 6 of 6
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,295,535 | Clostridium Difficile Dehydrogenase and Toxin as a Biomarker for Monitoring Infection in Patients with Clostridium Difficile Disease and Differentiating Carrier State from Active Disease In force · Medium confidence | In force | Medium confidence | |
| US 8,790,880 | CYSTEINE PROTEASE Cwp84 (CD2787) AS A DIAGNOSTIC MARKER FOR CLOSTRIDIUM DIFFICILE In force · High confidence | In force | High confidence | |
| US 10,295,536 | Fecal Lactoferrin as a Biomarker for Determining Disease Severity and for Treating Infection in Patients with Clostridium Difficile Disease In force · Low confidence | In force | Low confidence | |
| US 9,133,527 | CELL WALL PROTEIN CwpV (CD0514) AS A DIAGNOSTIC MARKER FOR CLOSTRIDIUM DIFFICILE RIBOTYPE 027 In force · High confidence | In force | High confidence | |
| US 9,528,105 | Nucleic Acid Extraction Using Organic Solvents to Remove Inhibitors In force · High confidence | In force | High confidence | |
| US 10,196,632 | Nucleic Acid Extraction Using Organic Solvents to Remove Inhibitors In force · High confidence | In force | High confidence |
Also on record, not counted in the 6: 2 lapsed for an unpaid fee · 10 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 abandoned · 4 no status recorded